SCHEMBL6000148

SCHEMBL6000148

CN(CCC(=O)O)Cc1nc(-c2ccc(NCCc3ccc(C4CCCCC4)cc3)cc2)cs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
MRE11 P49959 1/20 0.38
S1PR1 P21453 4/20 0.38
S1PR5 Q9H228 4/20 0.38
S1PR3 Q99500 3/20 0.38
NAMPT P43490 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GCGR P47871 3/20 0.37
TRPA1 O75762 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5999224 0.92 NPC1 (0.41) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL5999737 0.89 RAB9A (0.40) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL5999152 0.88 MEN1 (0.43) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000700 0.86 NPC1 (0.39) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000055 0.86 NPC1 (0.39) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000143 0.85 MRE11 (0.40) MRE11S1PR1S1PR5S1PR3GCGR
SCHEMBL6000151 0.85 GCGR (0.41) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL5999925 0.85 PTPN2 (0.39) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6001062 0.85 RAB9A (0.39) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL5999893 0.85 RAB9A (0.39) NPC1RAB9AMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 NPC1 955/4885RAB9A 1393/4885MEN1 4550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.